Winel Fonbah: Elevating Anticoagulation Literacy
Winel Fonbah, Registered Nurse at Regional hospital limbe, shared a post on LinkedIn:
“Elevating Anticoagulation Literacy: A Must-Know Guide for Clinicians!
Navigating the landscape of anticoagulants is fundamental for patient safety and effective treatment of conditions like AFib, DVT, and PE. I came across this excellent breakdown (shared below) and wanted to add some crucial context and clinical insights for my fellow healthcare professionals.
Anticoagulants: The Unsung Heroes of Cardiovascular Care.
In healthcare, few medication classes have as much impact on patient safety as anticoagulants, meds that prevent existing blood clots from getting bigger and stop new ones from forming.
While we often focus on the big names—Heparin, Warfarin (Coumadin), and newer Direct Oral Anticoagulants (DOACs)—what’s equally important is understanding how they differ, how they’re monitored, and how we keep patients safe.
Key Insights:
- Heparin: Fast-acting, short-term therapy; requires aPTT monitoring and has an antidote (Protamine sulfate). Watch for heparin-induced thrombocytopenia.
- Warfarin: Long-term therapy that needs consistent Vitamin K intake and regular INR monitoring, It has a slower onset, with antidotes including Vitamin K and FFP.
- DOACs: A newer class offering long-term protection with fewer monitoring requirements and fewer food interactions. Recently, more antidotes have been approved—making them even safer.
Across all anticoagulants, bleeding precautions remain essential, from avoiding aspirin to using soft toothbrushes and minimizing invasive procedures.
As clinicians, educators, or healthcare leaders, staying updated on these meds isn’t just knowledge—it’s patient safety.
Question for you:
- What’s one insight or tip you think every new nurse or healthcare student should know about anticoagulants?
Drop it in the comments—let’s build a resource together.”

Stay informed with Hemostasis Today.
-
Jan 14, 2026, 16:22Leo Nicolai and Rainer Kaiser Link Procoagulant Platelets and Thromboinflammation in CVD
-
Jan 14, 2026, 16:01Renato Simonetti Presents a Pilot Project on AI-assisted Duplex Sonography for ICH
-
Jan 14, 2026, 15:47An Unusual Case from Mohammed Ameen: Unexpected Clot Unmasking Antithrombin III Deficiency
-
Jan 14, 2026, 11:38Khokon Miah Akanda Shares A major 4-Guideline Comparison on BP Management in Stroke
-
Jan 14, 2026, 11:26Pablo Albasanz-García and Colleagues on Anticancer Treatment-Induced Arterial and Venous Thrombosis
-
Jan 14, 2026, 11:16ISTH 2026: Laurent Bertoletti To Serve as Vice Theme Leader for VTE
-
Jan 14, 2026, 11:08Leni von Bonsdorff Invites You to Hear and Learn The Latest News in The Plasma Field
-
Jan 14, 2026, 05:56Arun V J on The “Whole Blood” Nostalgia Trap
-
Jan 13, 2026, 16:38Caitlin Raymond: Understanding TAMOF as a TTP-Like Process
